statistiche ricercatore

Continente	#
NA - Nord America	1.124
AS - Asia	421
EU - Europa	338
SA - Sud America	67
AF - Africa	10
Continente sconosciuto - Info sul continente non disponibili	2
Totale	1.962

Nazione	#
US - Stati Uniti d'America	1.085
SG - Singapore	148
CN - Cina	91
GB - Regno Unito	86
VN - Vietnam	63
IT - Italia	54
BR - Brasile	51
SE - Svezia	47
HK - Hong Kong	46
DE - Germania	44
FI - Finlandia	21
FR - Francia	19
RU - Federazione Russa	19
BD - Bangladesh	18
CA - Canada	15
IN - India	14
MX - Messico	13
AR - Argentina	8
BG - Bulgaria	8
IQ - Iraq	8
LT - Lituania	8
BE - Belgio	7
KR - Corea	7
UA - Ucraina	6
DZ - Algeria	5
ID - Indonesia	5
PK - Pakistan	5
AT - Austria	4
JM - Giamaica	4
PL - Polonia	4
GT - Guatemala	3
VE - Venezuela	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
JP - Giappone	2
MY - Malesia	2
NL - Olanda	2
PE - Perù	2
UZ - Uzbekistan	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
AZ - Azerbaigian	1
BO - Bolivia	1
BY - Bielorussia	1
CH - Svizzera	1
CO - Colombia	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
EG - Egitto	1
ES - Italia	1
EU - Europa	1
GP - Guadalupe	1
IE - Irlanda	1
JO - Giordania	1
KG - Kirghizistan	1
KZ - Kazakistan	1
MA - Marocco	1
MD - Moldavia	1
OM - Oman	1
PA - Panama	1
PT - Portogallo	1
RO - Romania	1
SA - Arabia Saudita	1
SI - Slovenia	1
TH - Thailandia	1
TR - Turchia	1
TT - Trinidad e Tobago	1
Totale	1.962

Nome	#
Physician–patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy	276
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients	240
Improving the disease awareness: how a communication campaign brings hidradenitis suppurativa to the light	236
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis	226
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study	221
Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience	216
Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates – Italian Registry Hidradenitis Suppurativa project 2	199
Advances in ultrafast plasmonics	177
From north to south: exploring Italian sun-exposure habits through the “Save your skin” campaign	160
Clinical management of pigmented purpuric dermatoses: evidence from a survey among the Study Group on Cutaneous Vascular Diseases of the Italian Society of Dermatology and Venereology	28
Totale	1.979

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	179	6	9	10	12	3	23	1	8	16	10	64	17
2022/2023	151	20	23	10	19	24	17	2	8	11	3	5	9
2023/2024	92	2	1	11	17	17	4	17	5	2	1	11	4
2024/2025	351	10	3	4	42	67	48	23	23	40	23	30	38
2025/2026	728	52	21	33	52	96	36	74	33	68	79	76	108
2026/2027	55	55	0	0	0	0	0	0	0	0	0	0	0
Totale													1.979